Tag: gw pharmecuticals

BREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine

The U.S. Federal Drug Administration has given unprecedented approval for two separate trials of Epidiolex, a liquid medicine made entirely of cannabis; the substance contains 98% cannabidiol, a nonpsychoactive compound found in cannabis – the remaining 2% consist of various trace amounts of other cannabinoids. The studies will be led by Orrin Devinsky, MD at …

Continue reading